Fsoalex, Reduced progression to severe disease
Post# of 148168
(Total Views: 654)
Posted On: 10/29/2020 6:48:11 AM
Fsoalex,
Reduced progression to severe disease and few SAEs equate to lower need for critical care services.
The primary endpoint of symptom resolution was not significant at 14 days, as nearly all patients resolved by then, but was apparently significant at 3 days.
I believe Cytodyn, regardless of results, remains a relative unknown that has yet to "prove" itself in the larger regulatory and clinical arena.
Reduced progression to severe disease and few SAEs equate to lower need for critical care services.
The primary endpoint of symptom resolution was not significant at 14 days, as nearly all patients resolved by then, but was apparently significant at 3 days.
I believe Cytodyn, regardless of results, remains a relative unknown that has yet to "prove" itself in the larger regulatory and clinical arena.
(1)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼